Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

NanoViricides reports initial results from mouse studies of HivCide-I for HIV/AIDS

May 7, 2008

European Commission approves HIV protease inhibitor Aptivus

April 29, 2008

Recent Tibotec patent reports novel anti-HIV agents

April 25, 2008

Antiviral effects of rapamycin in mouse model of HIV infection

April 18, 2008

Theratechnologies treats last patient in phase III trial of tesamorelin in lipodystrophy

April 17, 2008

Novel non-nucleoside reverse transcriptase inhibitor synthesized at Merck

April 17, 2008

Vicriviroc begins phase II study in treatment-naive HIV patients

April 17, 2008

Recent Roche patent imparts new anti-HIV agents

April 15, 2008

Abacavir, didanosine linked to increased risk of myocardial infarction

April 11, 2008

New agents for HIV infection reported in recent Osaka University patent

April 8, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...